The French champion of Tests
Of Rapid Diagnosis (RDT)
Biosynex focuses its development choices on both high value-added niche marketsand innovative medical applications in the field of rapid diagnostic testing. By its desire to be a recognized forerunner in RDTs, the group has put in placea proactive intellectual property protection policy by filing its own patents.
A specialized R&D department in the in vitro diagnostics industry
The R & D department employs many scientists; enjoys a high-performance technology platform but also industrial and academic partnerships to design recognized home products.